US Stock MarketDetailed Quotes

ALX Oncology (ALXO)

Watchlist
  • 1.680
  • 0.0000.00%
Close Apr 16 16:00 ET
  • 1.710
  • +0.030+1.79%
Post 19:56 ET
221.10MMarket Cap-0.88P/E (TTM)

ALX Oncology (ALXO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-29.21%100.85M
-24.80%23.02M
-30.81%22.53M
-43.47%23.47M
-15.74%31.82M
-16.33%142.47M
-36.25%30.61M
-38.87%32.57M
12.91%41.53M
17.26%37.76M
Selling and administrative expenses
-8.60%23.85M
-24.08%5.38M
-16.49%5.09M
-20.68%5.45M
31.22%7.93M
-8.39%26.09M
13.50%7.08M
-18.82%6.1M
-5.80%6.87M
-18.75%6.05M
-General and administrative expense
-8.60%23.85M
-24.08%5.38M
-16.49%5.09M
-20.68%5.45M
31.22%7.93M
-8.39%26.09M
13.50%7.08M
-18.82%6.1M
-5.80%6.87M
-18.75%6.05M
Research and development costs
-33.84%77M
-25.02%17.65M
-34.11%17.44M
-47.99%18.02M
-24.68%23.89M
-17.93%116.37M
-43.68%23.53M
-42.16%26.47M
17.54%34.65M
28.08%31.72M
Operating profit
29.21%-100.85M
24.80%-23.02M
30.81%-22.53M
43.47%-23.47M
15.74%-31.82M
16.33%-142.47M
36.25%-30.61M
38.87%-32.57M
-12.91%-41.53M
-17.26%-37.76M
Net non-operating interest income expense
-69.07%2.36M
-86.91%190K
-78.78%394K
-67.15%701K
-50.93%1.08M
-15.93%7.64M
-43.76%1.45M
-18.77%1.86M
-6.97%2.13M
14.09%2.2M
Non-operating interest income
-57.68%3.96M
-69.49%573K
-65.18%802K
-56.85%1.11M
-43.44%1.48M
-12.05%9.37M
-37.30%1.88M
-13.97%2.3M
-3.86%2.56M
13.46%2.62M
Non-operating interest expense
-7.35%1.6M
-10.30%383K
-8.52%408K
-5.59%405K
-4.92%406K
10.48%1.73M
2.89%427K
14.07%446K
15.32%429K
10.34%427K
Other net income (expense)
-15,955.00%-3.21M
-1,600.00%-17K
-300.00%-6K
-39,612.50%-3.18M
21.43%-11K
-105.14%-20K
96.55%-1K
400.00%3K
-102.47%-8K
-114.74%-14K
Special income (charges)
---3.18M
--0
--0
---3.18M
----
--0
--0
--0
--0
----
-Less:Impairment of capital assets
----
----
--0
--3.18M
----
----
----
--0
--0
----
-Write off
--3.18M
--0
--0
--3.18M
----
--0
--0
--0
--0
----
Other non- operating income (expenses)
-80.00%-36K
-1,600.00%-17K
-300.00%-6K
75.00%-2K
21.43%-11K
-105.14%-20K
96.55%-1K
400.00%3K
-102.47%-8K
-114.74%-14K
Income before tax
24.59%-101.7M
21.65%-22.85M
27.89%-22.14M
34.14%-25.95M
13.57%-30.75M
16.14%-134.85M
35.87%-29.16M
39.78%-30.71M
-15.34%-39.4M
-17.88%-35.58M
Income tax
0
0
Net income
24.59%-101.7M
21.65%-22.85M
27.89%-22.14M
34.14%-25.95M
13.57%-30.75M
16.14%-134.85M
35.87%-29.16M
39.78%-30.71M
-15.34%-39.4M
-17.88%-35.58M
Net income continuous Operations
24.59%-101.7M
21.65%-22.85M
27.89%-22.14M
34.14%-25.95M
13.57%-30.75M
16.14%-134.85M
35.87%-29.16M
39.78%-30.71M
-15.34%-39.4M
-17.88%-35.58M
Minority interest income
Net income attributable to the parent company
24.59%-101.7M
21.65%-22.85M
27.89%-22.14M
34.14%-25.95M
13.57%-30.75M
16.14%-134.85M
35.87%-29.16M
39.78%-30.71M
-15.34%-39.4M
-17.88%-35.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
24.59%-101.7M
21.65%-22.85M
27.89%-22.14M
34.14%-25.95M
13.57%-30.75M
16.14%-134.85M
35.87%-29.16M
39.78%-30.71M
-15.34%-39.4M
-17.88%-35.58M
Basic earnings per share
26.36%-1.9
23.64%-0.42
29.31%-0.41
35.53%-0.49
18.31%-0.58
31.02%-2.58
40.22%-0.55
53.23%-0.58
9.52%-0.76
4.05%-0.71
Diluted earnings per share
26.36%-1.9
23.64%-0.42
29.31%-0.41
35.53%-0.49
18.31%-0.58
31.02%-2.58
40.22%-0.55
53.23%-0.58
9.52%-0.76
4.05%-0.71
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -29.21%100.85M-24.80%23.02M-30.81%22.53M-43.47%23.47M-15.74%31.82M-16.33%142.47M-36.25%30.61M-38.87%32.57M12.91%41.53M17.26%37.76M
Selling and administrative expenses -8.60%23.85M-24.08%5.38M-16.49%5.09M-20.68%5.45M31.22%7.93M-8.39%26.09M13.50%7.08M-18.82%6.1M-5.80%6.87M-18.75%6.05M
-General and administrative expense -8.60%23.85M-24.08%5.38M-16.49%5.09M-20.68%5.45M31.22%7.93M-8.39%26.09M13.50%7.08M-18.82%6.1M-5.80%6.87M-18.75%6.05M
Research and development costs -33.84%77M-25.02%17.65M-34.11%17.44M-47.99%18.02M-24.68%23.89M-17.93%116.37M-43.68%23.53M-42.16%26.47M17.54%34.65M28.08%31.72M
Operating profit 29.21%-100.85M24.80%-23.02M30.81%-22.53M43.47%-23.47M15.74%-31.82M16.33%-142.47M36.25%-30.61M38.87%-32.57M-12.91%-41.53M-17.26%-37.76M
Net non-operating interest income expense -69.07%2.36M-86.91%190K-78.78%394K-67.15%701K-50.93%1.08M-15.93%7.64M-43.76%1.45M-18.77%1.86M-6.97%2.13M14.09%2.2M
Non-operating interest income -57.68%3.96M-69.49%573K-65.18%802K-56.85%1.11M-43.44%1.48M-12.05%9.37M-37.30%1.88M-13.97%2.3M-3.86%2.56M13.46%2.62M
Non-operating interest expense -7.35%1.6M-10.30%383K-8.52%408K-5.59%405K-4.92%406K10.48%1.73M2.89%427K14.07%446K15.32%429K10.34%427K
Other net income (expense) -15,955.00%-3.21M-1,600.00%-17K-300.00%-6K-39,612.50%-3.18M21.43%-11K-105.14%-20K96.55%-1K400.00%3K-102.47%-8K-114.74%-14K
Special income (charges) ---3.18M--0--0---3.18M------0--0--0--0----
-Less:Impairment of capital assets ----------0--3.18M--------------0--0----
-Write off --3.18M--0--0--3.18M------0--0--0--0----
Other non- operating income (expenses) -80.00%-36K-1,600.00%-17K-300.00%-6K75.00%-2K21.43%-11K-105.14%-20K96.55%-1K400.00%3K-102.47%-8K-114.74%-14K
Income before tax 24.59%-101.7M21.65%-22.85M27.89%-22.14M34.14%-25.95M13.57%-30.75M16.14%-134.85M35.87%-29.16M39.78%-30.71M-15.34%-39.4M-17.88%-35.58M
Income tax 00
Net income 24.59%-101.7M21.65%-22.85M27.89%-22.14M34.14%-25.95M13.57%-30.75M16.14%-134.85M35.87%-29.16M39.78%-30.71M-15.34%-39.4M-17.88%-35.58M
Net income continuous Operations 24.59%-101.7M21.65%-22.85M27.89%-22.14M34.14%-25.95M13.57%-30.75M16.14%-134.85M35.87%-29.16M39.78%-30.71M-15.34%-39.4M-17.88%-35.58M
Minority interest income
Net income attributable to the parent company 24.59%-101.7M21.65%-22.85M27.89%-22.14M34.14%-25.95M13.57%-30.75M16.14%-134.85M35.87%-29.16M39.78%-30.71M-15.34%-39.4M-17.88%-35.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 24.59%-101.7M21.65%-22.85M27.89%-22.14M34.14%-25.95M13.57%-30.75M16.14%-134.85M35.87%-29.16M39.78%-30.71M-15.34%-39.4M-17.88%-35.58M
Basic earnings per share 26.36%-1.923.64%-0.4229.31%-0.4135.53%-0.4918.31%-0.5831.02%-2.5840.22%-0.5553.23%-0.589.52%-0.764.05%-0.71
Diluted earnings per share 26.36%-1.923.64%-0.4229.31%-0.4135.53%-0.4918.31%-0.5831.02%-2.5840.22%-0.5553.23%-0.589.52%-0.764.05%-0.71
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More